# Clinical Study on the Safety and Efficacy of CD7 CAR-T Cell Sequential Allo-HSCT and Kidney Transplantation in the Treatment of SIOD

> **NCT06769191** · EARLY_PHASE1 · RECRUITING · sponsor: **Zhejiang University** · enrollment: 20 (estimated)

## Conditions studied

- Schimke Immuno-osseous Dysplasia

## Interventions

- **BIOLOGICAL:** CD7 CAR-T cells injection
- **PROCEDURE:** Allo-HSCT
- **PROCEDURE:** Kidney Transplantation

## Key facts

- **NCT ID:** NCT06769191
- **Lead sponsor:** Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-30
- **Primary completion:** 2028-01-30
- **Final completion:** 2028-01-30
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-01-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06769191

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06769191, "Clinical Study on the Safety and Efficacy of CD7 CAR-T Cell Sequential Allo-HSCT and Kidney Transplantation in the Treatment of SIOD". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06769191. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*